Cargando…
Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways
Chemotherapy-induced intestinal mucositis, a painful debilitating condition affecting up to 40–100% of patients undergoing chemotherapy, can reduce the patients’ quality of life, add health care costs and even postpone cancer treatment. In recent years, the relationships between intestinal microbiot...
Autores principales: | Wei, Ling, Wen, Xue-Sen, Xian, Cory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431669/ https://www.ncbi.nlm.nih.gov/pubmed/34502383 http://dx.doi.org/10.3390/ijms22179474 |
Ejemplares similares
-
Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis
por: Hu, Ze Bo, et al.
Publicado: (2020) -
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
por: Jiang, Weiwei, et al.
Publicado: (2015) -
Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances
por: Williams, Brent L., et al.
Publicado: (2011) -
Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease
por: Raj, Ashok S., et al.
Publicado: (2019) -
Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients
por: Pan, Zhaoyi, et al.
Publicado: (2023)